4.8 Review

Tetanus

期刊

LANCET
卷 393, 期 10181, 页码 1657-1668

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(18)33131-3

关键词

-

资金

  1. Wellcome Trust Major Overseas Programme [106680/B/14/Z]
  2. Wellcome Trust [107367/Z/15/Z]
  3. Wellcome Trust [107367/Z/15/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

Tetanus is a vaccine-preventable disease that still commonly occurs in many low-income and middle-income countries, although it is rare in high-income countries. The disease is caused by the toxin of the bacterium Clostridium tetani and is characterised by muscle spasms and autonomic nervous system dysfunction. Global vaccination initiatives have had considerable success but they continue to face many challenges. Treatment for tetanus aims to control spasms and reduce cardiovascular instability, and consists of wound debridement, antitoxin, antibiotics, and supportive care. Recent research has focused on intravenous magnesium sulphate and intrathecal antitoxin administration as methods of spasm control that can avoid the need for ventilatory support. Nevertheless, without access to mechanical ventilation, mortality from tetanus remains high. Even with such care, patients require several weeks of hospitalisation and are vulnerable to secondary problems, such as hospital-acquired infections.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据